Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Edwards maintained its prior guidance for full-year sales growth of 8-10%, and expects Q4 sales of $1.33 billion to $1.39 ...

Medtronic announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) ...

Philips (NYSE:PHG) and Medtronic (NYSE:MDT) today announced a strategic advocacy partnership centered around stroke care.

Adagio Medical (Nasdaq:ADGM) today announced the first completed procedure in an FDA IDE study of its VT cryoablation system.

Sonavex announced today that it closed a $15 million Series A-2 financing round to support its ultrasound technologies.

Align Technology (Nasdaq:ALGN) announced that it released the next innovation of its Invisalign Smile Architect software.

The UK's National Institute for Health and Care Excellence (NICE) guidance supports the Boston Scientific (NYSE:BSX) ...

Abbott (NYSE:ABT) announced today that it launched a new clinical trial to help heart failure patients with advanced therapy ...

The Duo tricuspid valve repair device in the heart. [Image courtesy of CroíValve] CroíValve today announced the first patient ...

Boston Scientific reported third-quarter results that came in ahead of the consensus forecast, raising its 2024 guidance ...

Allurion Technologies announced today that it submitted three modules for its weight loss balloon to the FDA for premarket ...